This federal contract award is for the provision of Novocure Inc.'s proprietary Optune Tumor Treating Fields (TTFields) therapy products and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 firm-fixed-price delivery order was issued under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a ceiling value of $28.85 million. The contract does not utilize any set-aside designations....
This federal contract award to Novocure Inc., a foreign-owned medical device manufacturer, is for the provision of the Optune Plus Transducers system, a non-invasive cancer treatment technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The $49,748.73 firm fixed-price contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Novocure as the prime contractor. The award does not...
This federal contract award to Novocure Inc., a foreign-owned manufacturer of medical devices, is for the provision of Optune Plus transducers, device rentals, and related support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is a Firm Fixed Price delivery order awarded under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a ceiling value of $28.85 million. This multiple-award...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of the company's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The award, valued at $45,600.00, is a Firm Fixed Price Purchase Order with a period of performance through February 28, 2025. The...
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, is for the provision of the Optune system, a cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The $49,748.73 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 12 (VISN 12) for the delivery of Optune medical devices, transducer arrays, rental...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of TFH 9000 OPTUNE PLUS TRANSDUCERS for the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $84,000.00 firm fixed-price purchase order, awarded on June 29, 2020, has an ultimate completion date of December 29, 2020. The contract does not utilize any set-aside designations. Novocure is the prime contractor and is delivering its...
This federal contract award is for the procurement of Optune Plus transducers from Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy. The $16,582.91 firm-fixed price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc. as the prime contractor. The contract has an ultimate completion date of March 28, 2025 and does not utilize any set-aside designations. Novocure...
This federal contract award is for the provision of Novocure Inc.'s Optune tumor treating fields (TTFields) therapy devices, transducers, rentals, and support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract is a firm fixed price purchase order with a potential value of $105,000.00. Novocure, a foreign-owned, for-profit medical technology company, is the prime contractor for this order, which does not have a set-aside designation. The...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a delivery order contract to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, for the provision of Optune Plus transducers and related cancer therapy support services. The contract, valued at $49,748.73, has a completion date of September 8, 2024, and was issued under Novocure's existing 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a ceiling value of $28.85...
This federal contract award is for the provision of Novocure Inc.'s Optune PLUS Transducer system, a medical device used to deliver tumor treating fields (TTFields) therapy for the treatment of solid tumor cancers. The $126,000.00 firm fixed price award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 9 to Novocure Inc., a foreign-owned for-profit company, with a period of performance ending on September 30, 2020....